Figure 2

The effect of olmesartan on systolic blood pressure (SBP) and heart rate (HR). Time course of SBP and HR in the groups during the study period. ^#P<0.001 vs. SBP of the no-treatment group for both the olmesartan and hydralazine (Hyd)/hydrochlorothiazide (HCT) groups; ^*P<0.05 vs. HR of the no-treatment group for the Hyd/HCT group.